SEGMENT REPORTING

The Company is composed of two reportable segments, CCA and OVP. The CCA segment includes Point of Care diagnostics laboratory instruments and consumables, and Point of Care digital imaging diagnostic instruments and software services as well as single use diagnostic and other tests, pharmaceuticals and vaccines, primarily for canine and feline use. These products are sold directly by the Company as well as through independent third-party distributors and through other distribution relationships. CCA segment products manufactured at the Des Moines, Iowa production facility included in the OVP segment's assets are transferred at cost and are not recorded as revenue for the OVP segment. The OVP segment includes private label vaccine and pharmaceutical production, primarily for cattle, but also for other animals including small mammals. All OVP products are sold by third parties under third-party labels.

Summarized financial information concerning the Company's reportable segments is shown in the following tables (in thousands):



Three Months Ended June 30, 2018	Core Companion Animal Health		Other Vaccines, Pharmaceuticals and Products			Total
Total revenue	$	26,644	$	3,018		$	29,662
Operating income (loss)	2,864		(660		)	2,204
Income (loss) before income taxes	2,772		(660		)	2,112
Capital purchases	39		397			436
Depreciation and amortization	838		300			1,138



Three Months Ended June 30, 2017	Core Companion Animal Health		Other Vaccines, Pharmaceuticals and Products		Total
Total revenue	$	26,090	$	7,315	$	33,405
Operating income	2,549		2,011		4,560
Income before income taxes	2,683		1,995		4,678
Capital purchases	36		779		815
Depreciation and amortization	857		243		1,100



Six Months Ended June 30, 2018	Core Companion Animal Health		Other Vaccines, Pharmaceuticals and Products			Total
Total revenue	$	53,463	$	8,964		$	62,427
Operating Income (loss)	4,787		(712		)	4,075
Income (loss) before income taxes	4,699		(712		)	3,987
Capital expenditures	96		715			811
Depreciation and amortization	1,746		587			2,333



Six Months Ended June 30, 2017	Core Companion Animal Health		Other Vaccines, Pharmaceuticals and Products		Total
Total revenue	$	49,875	$	13,089	$	62,964
Operating income	3,695		3,653		7,348
Income before income taxes	3,897		3,631		7,528
Capital purchases	85		1,210		1,295
Depreciation and amortization	1,702		490		2,192

Asset information by reportable segment as of June 30, 2018 is as follows (in thousands):



	Core Companion Animal Health		Other Vaccines, Pharmaceuticals and Products		Total
Total assets	$	118,074	$	19,953	$	138,027
Net assets	86,178		23,744		109,922

Asset information by reportable segment as of December 31, 2017 is as follows (in thousands):



	Core Companion Animal Health		Other Vaccines, Pharmaceuticals and Products		Total
Total assets	$	111,968	$	23,819	$	135,787
Net assets	75,984		24,456		100,440